FIBCD1 and cancer: Further evidence demonstrating that FIBCD1 is a receptor for chondroitin sulfate proteoglycans of the brain extracellular matrix has also been reported (6), while early data suggest a protective role for soluble FIBCD1 as a myokine in vivo in a model for cancer-induced myofiber atrophy (7).